Prosecution Insights
Last updated: November 04, 2026

Eyecool Therapeutics Inc.

Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering

2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Analysis

Eyecool Therapeutics Inc. manages 2 pending office actions in the Medical Devices & Mechanical Engineering technology area. These matters are assigned to 2 distinct examiners across 2 distinct art units. This distribution means that each of the 2 pending office actions is being reviewed by a different examiner. This lack of overlap requires a tailored approach for each of the 2 pending office actions.

ARBLE, JESSICA R is the busiest examiner with 1 pending office action. With 2 distinct examiners and 2 distinct art units, the company's current medical device portfolio is split between two different technical divisions. This distribution requires managing two independent prosecution tracks for its mechanical innovations. The company must navigate the specific requirements of 2 different art units to advance its current portfolio. Each of the 2 pending office actions represents a unique technical hurdle in the medical device sector. The resolution of these 2 pending office actions will define the company's immediate progress.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
1
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
1
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (50%)
1
Medium (50%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (50%)
§103 only1 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
50% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
50% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
ARBLE, JESSICA R 1 66.7% +25.1%
BASQUILL, SEAN M 1 38.7% +21.6%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18907345 METHODS OF ALLEVIATING SYMPTOMS OF OCULAR SURFACE DISCOMFORT USING MEDICAL ICE SLURRY BASQUILL, SEAN M —

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18948163 METHODS OF ALLEVIATING SYMPTOMS OF OCULAR SURFACE DISCOMFORT USING MEDICAL ICE SLURRY ARBLE, JESSICA R 5d
18907345 METHODS OF ALLEVIATING SYMPTOMS OF OCULAR SURFACE DISCOMFORT USING MEDICAL ICE SLURRY BASQUILL, SEAN M —

Top Art Units

Art UnitApps
3781 1
1614 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18948163 METHODS OF ALLEVIATING SYMPTOMS OF OCULAR SURFACE DISCOMFORT USING MEDICAL ICE SLURRY ARBLE, JESSICA R 3781 §103 Final Rejection 5d Pending Nov 14, 2024
18907345 METHODS OF ALLEVIATING SYMPTOMS OF OCULAR SURFACE DISCOMFORT USING MEDICAL ICE SLURRY BASQUILL, SEAN M 1614 §101DP Non-Final OA — Pending Oct 04, 2024

Managing Eyecool Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Eyecool Therapeutics Inc. have?

Eyecool Therapeutics Inc. has 2 pending office actions as of November 2026, spread across 2 art units and 2 examiners.

Which USPTO examiner handles the most Eyecool Therapeutics Inc. applications?

Jessica R Arble has the most, with 1 of Eyecool Therapeutics Inc.'s pending office actions.

What technology area are Eyecool Therapeutics Inc.'s patent applications in?

Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month